References
- Kovacs SO. Vitiligo. J Am Acad Dermatol. 1998;38:647–666.
- Mahmoud BH, Hexsel CL, Hamzavi IH. An update on new and emerging options for the treatment of vitiligo. Skin Therapy Lett. 2008;13:1–6.
- Porter JR, Beuf AH, Lerner AB, Nordlund JJ. Response to cosmetic disfigurement: patients with vitiligo. Cutis. 1987;39:493–494.
- Agarwal G. Vitiligo: an underestimated problem. Fam Pract. 1997;15:S19–S23.
- Grimes PE, Kenney JA. Should vitiligo be treated? Cutis. 1983;32:343–346.
- Radtke MA, Schäfer I, Gajur A, Langenbruch A, Augustin M. Willingness-to-pay and quality of life in patients with vitiligo. Br J Dermatol. 2009;161:134–139.
- AlGhamdi KM. Beliefs and perceptions of Arab vitiligo patients regarding their condition. Int J Dermatol. 2010;49:1141–1145.
- Ongenae K, Van Geel N, De Schepper S, Vander Haeghen Y, Naeyaert JM. Management of vitiligo patients and attitude of dermatologists towards vitiligo. Eur J Dermatol. 2004;14:177–181.
- AlGhamdi KM. A survey of vitiligo management among dermatologists in Saudi Arabia. J Eur Acad Dermatol Venereol. 2009;23:1282–1288.
- Njoo MD, Bossuyt PMM, Westerhof W. Management of vitiligo. Results of a questionnaire among dermatologists in the Netherlands. Int J Dermatol. 1999;38:866–872.
- Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, et al. Guidelines of care for vitiligo. American Academy of Dermatology. J Am Acad Dermatol. 1996;35:620–626.
- Chun WH, Hann SK. The progression of non-segmental vitiligo: clinical analysis of 318 patients. Int J Dermatol. 1997;36:908–910.
- Hann SK, Chun WH, Park YK. Clinical characteristics of progressive vitiligo. Int J Dermatol. 1997;36:353–355.
- Grimes PE. New insights and new therapies in vitiligo. JAMA. 2005;293:730–735.
- Al-Qattan MM. Pediatric burns induced by psoralens in Saudi Arabia. Burns. 2000;26:653–655.
- Berneburg M, Rocken M, Benedic F. Phototherapy with narrowband vs. broadband UVB. Acta Derm Venereol. 2005;85:98–108.
- Parsad D, Kanwar AJ, Kumar B. Psoralen-ultraviolet A. vs. Narrow-band ultraviolet B phototherapy for the treatment of vitiligo. J Eur Acad Dermatol Venereol. 2006;20:175–177.
- Yones SS, Palmer RA, Garibaldinos TM, Hawk JL. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UVA therapy vs. Narrowband–UVB Therapy. Arch Dermatol. 2007;143:578–584.
- Kostovic K, Pasic A. New treatment modalities for vitiligo focus on topical immunomodulators. Drugs. 2005;65:447–459.
- Lepe V, Moncada B, Castanedo-Cazares JP, Torres-Alvarez MB, Ortiz CA, Torres-Rubalcava AB. Double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. Arch Dermatol. 2003;139:581–585.
- Hadi S, Tinio P, Al-Ghaithi K, Al-Qari H, Al-Helalat M, Lebwohl M, et al. Treatment of vitiligo using the 308 nm excimer laser. Photomed Laser Surg. 2006;24:354–357.